Post by
lonc17 on Sep 28, 2022 10:59am
Adlai Nortye
Pelareorep has been removed from Adlai Nortye's website (sometime during the past three weeks).
I have no idea what this means, but it is surprising.
https://www.adlainortye.com/index.php/products
Comment by
jimsenior on Sep 28, 2022 3:02pm
I have had to come out of retirement from the yahoo board to try and settle this AN situation. At the AN website look under patients, pela is there AKA AN 1004. AN can be found at clinicaltrials.gov, and are active, not recruiting. As always, if I am wrong, I am happy to stand corrected.
Comment by
Noteable on Sep 28, 2022 4:47pm
Agreed jimsenior. Also note that Oncolytics Biotech is still listed as one of Adalai Nortye's current partners, along with Novartis, MSD, Roche and Eisai. AND the licensing deal with ONCY for Reolysin still appears in their Business Development list of accomplishments. https://www.adlainortye.com/index.php/partner_cooperation https://www.adlainortye.com/index.php/partner_business
Comment by
Capitalista on Sep 29, 2022 8:11am
I'm not sure I follow your logic here, Noteable. Wouldn't the applicant just have to exclude the AN trial from the FDA application? AN is an independent company working in a different regulatory environment. Can you clarify?
Comment by
Noteable on Sep 29, 2022 11:34am
Have I answered your question Capitalista?
Comment by
Noteable on Oct 04, 2022 11:15am
Adlai Nortye's study was a dose escalation study wih pelareorep + paclitaxel and did not involve an immune checkpoint inhibitor to improve efficacy. Perhaps ONCY is closer to an acquition than anticipated.
Comment by
jimsenior on Oct 04, 2022 11:28am
Yes. I was thinking that this needs to be neatly tied together, and perhaps that was the thinking from the get-go. Anyway, just speculation on my part; big bucks and big brains needed. Will someone step up? We wait. Good luck.
Comment by
Noteable on Oct 04, 2022 11:28am
And then of course, Bidens's executive order may have also had some affect on ONCY's potential acquisitor and their globalization plans.
Comment by
Buckhenry on Sep 29, 2022 12:19pm
I second that... about 20% of the posts here have any useful information.
Comment by
Noteable on Sep 29, 2022 12:44pm
Just keeping it real as possible for someone like you with 3 seperate aliases - aka 'Da-Man' aka "dreamer" aka 'inthno". Just sayn'
Comment by
Noteable on Sep 29, 2022 1:05pm
I know what I know. And I don't need to pester anyone like you seem to do, to have arrived at what I know.
Comment by
Buckhenry on Sep 29, 2022 2:33pm
yes...you are a legend in your own mind. NO ONE .. unless your are an insider..like Martha Stuart... has no idea what or when something may happen with this stock. Been reading the same ole regurgitated posts for the last 3 years.